Columbia Pathology Associates Inc Danville, PA - 17821

Columbia Pathology Associates Inc is categorized under Pathological Laboratories in Danville, PA and active since 2001.

Columbia Pathology Associates Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.

If you are seeking more information, feel free to contact William E Titman at the company’s single location by writing to 25 Charles St, Danville, Pennsylvania PA 17821 or by phoning (407) 657-9500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Columbia Pathology Associates Inc
Contact Person: William E Titman
Address: 25 Charles St, Danville, Pennsylvania 17821
Phone Number: (407) 657-9500
Annual Revenue (USD): $100.000 to $499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pathological Laboratories
SIC Code: 8071
NAICS Code: 621511
Share This Business:

Columbia Pathology Associates Inc was started in 2001 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact William E Titman for inquiries that concern Columbia Pathology Associates Inc by calling the company number (407) 657-9500, as your correspondence is most welcome. Additionally, the physical location of the single location of Columbia Pathology Associates Inc can be found at the coordinates as well as the street address 25 Charles St in Danville, Pennsylvania 17821.

For its online presence, you may visit Columbia Pathology Associates Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.